Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 08 04 2019
revised: 11 06 2019
accepted: 15 07 2019
pubmed: 26 9 2019
medline: 27 5 2020
entrez: 26 9 2019
Statut: ppublish

Résumé

Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for patients with advanced Parkinson's disease improving quality of life, motor symptoms and non-motor symptoms. However, there is a considerable degree of interindividual variability for these outcomes, likely due to variability in electrode placement and stimulation settings. Here, we present probabilistic mapping data from a prospective, open-label, multicentre, international study to investigate the influence of the location of subthalamic nucleus deep brain stimulation on non-motor symptoms in patients with Parkinson's disease. A total of 91 Parkinson's disease patients undergoing bilateral deep brain stimulation of the subthalamic nucleus were included, and we investigated NMSScale, NMSQuestionnaire, Scales for Outcomes in Parkinson's disease-motor examination, -activities of daily living, and -motor complications, and Parkinson's disease Questionnaire-8 preoperatively and at 6-month follow-up after surgery. Leads were localized in standard space using the Lead-DBS toolbox and individual volumes of tissue activated were calculated based on clinical stimulation settings. Probabilistic stimulation maps and non-parametric permutation statistics were applied to identify voxels with significant above or below average improvement for each scale and analysed using the DISTAL atlas. All outcomes improved significantly at follow-up. Significant spatial distribution patterns of neurostimulation were observed for NMSScale total score and its mood/apathy and attention/memory domains. For both domains, voxels associated with below average improvement were mainly located dorsal to the subthalamic nucleus. In contrast, above average improvement for mood/apathy was observed in the ventral border region of the subthalamic nucleus and in its sensorimotor subregion and for attention/memory in the associative subregion. A trend was observed for NMSScale sleep domain showing voxels with above average improvement located ventral to the subthalamic nucleus. Our study provides evidence that the interindividual variability of mood/apathy, attention/memory, and sleep outcomes after subthalamic nucleus deep brain stimulation depends on the location of neurostimulation. This study highlights the importance of holistic assessments of motor and non-motor aspects of Parkinson's disease to tailor surgical targeting and stimulation parameter settings to patients' personal profiles.

Identifiants

pubmed: 31553039
pii: 5573074
doi: 10.1093/brain/awz285
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3592-3604

Investigateurs

Kallol Ray-Chaudhuri (K)
Angelo Antonini (A)
Pablo Martinez-Martin (P)
Per Odin (P)
Anette Schrag (A)
Daniel Weintraub (D)
Paolo Barone (P)
David J Brooks (DJ)
Richard G Brown (RG)
Peter Jenner (P)
B Jeon (B)
Kelly Lyons (K)
Nicola Pavese (N)
Marios Politis (M)
Ronald B Postuma (RB)
Anthony Schapira (A)
Fabrizio Stocchi (F)
Lars Timmermann (L)
Yoshio Tsuboi (Y)
Alexandra Rizos (A)
Anna Sauerbier (A)

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Jan Niklas Petry-Schmelzer (JN)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Max Krause (M)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Till A Dembek (TA)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Andreas Horn (A)

Department of Neurology, Charité - University Medicine Berlin, Berlin, Germany.

Julian Evans (J)

Department of Neurology and Neurosurgery, Salford Royal Foundation Thrust, Greater Manchester, UK.

Keyoumars Ashkan (K)

National Parkinson Foundation Centre of Excellence, King's College Hospital, London, UK.

Alexandra Rizos (A)

National Parkinson Foundation Centre of Excellence, King's College Hospital, London, UK.

Monty Silverdale (M)

Department of Neurology and Neurosurgery, Salford Royal Foundation Thrust, Greater Manchester, UK.

Wibke Schumacher (W)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Carolin Sack (C)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Philipp A Loehrer (PA)

Department of Neurology, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany.

Gereon R Fink (GR)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.
Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany.

Erich T Fonoff (ET)

Division of Functional Neurosurgery of Institute of Psychiatry, Department of Neurology, University of São Paulo Medical School, São Paulo, Brazil.

Pablo Martinez-Martin (P)

National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

Angelo Antonini (A)

Department of Neuroscience, University of Padua, Padua, Italy.

Michael T Barbe (MT)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.

Veerle Visser-Vandewalle (V)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Stereotaxy and Functional Neurosurgery, Cologne, Germany.

K Ray-Chaudhuri (K)

National Parkinson Foundation Centre of Excellence, King's College Hospital, London, UK.
The Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.

Lars Timmermann (L)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.
Department of Neurology, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany.

Haidar S Dafsari (HS)

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.
National Parkinson Foundation Centre of Excellence, King's College Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH